Pushkarmoola is beneficial for:
cardiovascular system
angina
dyspnea
Animal Research
In an experiment, rats were given Inula before and after experimental
myocardial infarction. Animals given Inula had smaller increases
in SGOT, LDH, CPK, CAMP, cortisol, pyruvate, lactate, and glucose
than those in an untreated control group. 1
Clinical Research
Inula was studied in combination with Guggul (Commiphora mukul)
using a 1:1 mixture. 200 patients with ischemic heart disease were
used in the trial. Approximately 80 percent experienced dyspnea,
and all 200 subjects had chest pain, with
positive indications of myocardial ischemia.
Guggul (Commiphora) is known for its lipid-lowering qualities. It
may partially explain the lowering of total cholesterol by 39-percent
in these patients. There was also a 51-percent decrease in triglycerides
and 32-percent decrease in total blood lipids.
The other results were also equally remarkable. At the end of the
six-month study period, 26 percent of the subjects had a complete
restoration of normal ECG. Another 59 percent showed improvement
in the ECG. Twenty-five percent of the subjects had no chest pain,
and patients experiencing dyspnea fell from 80 percent at the beginning
of the study to 32 percent. 2
In another trial, the efficacy of Inula was compared to nitroglycerin
for the prevention of anginal symptoms. Nine subjects with ischemic
heart disease was used in the study. All patients experienced chest
pain and showed positive for myocardial ischemia by their ECG ST-segment
depression on exertion. The Inula group received 3 grams root powder
90 minutes prior to testing. The controls were given nitroglycerin.
All nine subjects had improvement in ST-segment depression on ECG.
However, the improvement was greater for those who were given inula.
3
|